ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PHC Plant Health Care Plc

3.59
0.12 (3.46%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Plant Health Care Plc LSE:PHC London Ordinary Share GB00B01JC540 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.12 3.46% 3.59 3.30 3.86 3.62 3.44 3.56 675,665 16:35:07
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pesticides, Agric Chems, Nec 11.77M -9.48M -0.0278 -1.30 12.36M
Plant Health Care Plc is listed in the Pesticides, Agric Chems sector of the London Stock Exchange with ticker PHC. The last closing price for Plant Health Care was 3.47p. Over the last year, Plant Health Care shares have traded in a share price range of 3.20p to 11.60p.

Plant Health Care currently has 341,532,952 shares in issue. The market capitalisation of Plant Health Care is £12.36 million. Plant Health Care has a price to earnings ratio (PE ratio) of -1.30.

Plant Health Care Share Discussion Threads

Showing 376 to 400 of 1350 messages
Chat Pages: Latest  18  17  16  15  14  13  12  11  10  9  8  7  Older
DateSubjectAuthorDiscuss
30/8/2013
19:53
Any further news/views on the sharp decline in the share price since May.On the surface it will look buy at 50p.Sure there are some powerful reasons for the decline.
19wizard
26/6/2013
08:31
Nothing specific but board shake up, full funded, great product , good investors have large holdings, directors bought stock... All that adds up to watch this space IMHO
pinkalltheway
26/6/2013
07:57
Hi pink, have you any specific reason for thinking so? It's gone very quiet since the institutions finished their stake building. When are the results due?
bobdouthwaite
25/6/2013
19:27
I think this space is worth watching VERY closely.. Upside potential
pinkalltheway
02/5/2013
09:21
chairman makes first purchase of #50000. that's a good sign
cnx
17/1/2013
00:00
HENDERSON INVESTMENTS NOW OVER 24%
cnx
02/11/2012
12:41
ORA are keen, investing another £450k or so!

RNS: ORA (Guernsey) Ltd and Richard Griffiths increase stake to 22.49%

That explains the 450,730 trade on 31/10/12 @ 99p.

dlem
22/10/2012
17:10
perhaps mr.henderson and m. griffiths know more than we know?
cnx
22/10/2012
13:05
RNS: ORA (Guernsey) Ltd and Richard Griffiths increase stake to 21.65% from 18%
dlem
19/10/2012
15:14
RNS: Henderson Global Investors cross 23% increasing stake to 23.81% from 21%.

That only explains 1,410,332 of the 6,784,290 shares traded yesterday.

dlem
19/10/2012
08:50
Yes I noticed the action, but only 1,000 at 85p were mine! The institutions have been building stakes for some months now as sales in the US appear to be taking off - at long last!
bobdouthwaite
19/10/2012
08:30
6,784,290 Shares Traded Yesterday! That must cross an RNS threshold.
dlem
09/10/2012
08:25
mdrans1, it looks like you were correct regarding the directors being in a close period (which may have now ended with the issuing of the RNS below, unless there is more news pending).

9 October 2012

PLANT HEALTH CARE PLC

("Plant Health Care" or "the Company")

Significant increase in USA crop area treated with foliar Harpin in 2012
Plant Health Care plc, a leading provider of innovative patent protected biological products to the global agriculture markets, is pleased to announce strong first sales of a novel approach to fungicide resistance management. Foliar sprays of ProAct (a Harpin-based product), in mixture with triazole fungicides, were applied on approximately 200,000 acres of crops in the USA this season, with outstanding results. These sales significantly exceeded the company's market share expectations in the first year of commercial sales. The combination is of particular relevance as there is increasing concern about resistance to the strobilurin fungicides currently on the market.
Trials in 2011 conducted by the independent On-Farm Network in Iowa, USA, demonstrated that corn fields treated with a combination of ProAct and propiconazole fungicide delivered as good or better yield increases than those corn fields treated with BASF's market-leading Headline strobilurin-based product, which is marketed with plant health benefits. These findings, coupled with the Company's "Save the Strobies" marketing campaign, helped to drive sales of ProAct in mixture with triazoles up four times greater than the initial expectations of 50,000 treated acres.

Agricultural scientists across the USA are already seeing strong evidence of resistance developing to strobilurin-based fungicides in the USA, as has already been witnessed in Europe and South America. The combination of Harpin with the post patent fungicide propiconazole, used in rotation with strobilurin based products, is the type of program that has been recommended by the Fungicide Resistance Action Committee, an organisation that aims to preserve the efficacy of fungicides on a global basis.

John Brady, CEO of Plant Health Care, commented:
"The strength of the uptake of ProAct and propiconazole in its initial year is a very exciting development for Plant Health Care. Used together as a rotation product on corn, soybeans and other susceptible crops has proven to be a highly effective method for farmers to mitigate the risk of diseases developing resistance to strobilurin fungicides, while also maintaining the disease control and yield potential they have become accustomed to receiving. This product provides farmers with a new set of options, which is the basis for our existing agreements with Arysta LifeScience and Makhteshim Agan Industries. I am delighted by the enthusiastic recognition that our product and marketing message is receiving."

~ Ends ~

dlem
04/10/2012
17:13
He my have inside information which prevents him from buying.
mdrans1
04/10/2012
17:09
The book 'We want real food' makes a very interesting read and love the fungi
spondon
04/10/2012
17:07
I'm disappointed that Dr Richards has not yet purchased any shares in the company given his conclusion that Plant Health is at an "inflection" point, given his distinguished career and I assume high net worth status.

1st August 2012
Dr Richards said: "I am pleased to be joining Plant Health Care at an inflexion point in the Company's development.
Dr Richards has had a distinguished career in the global agrochemical industry and is the non-executive Chairman of Arysta
LifeScience Corporation ("Arysta LifeScience"), one of the world's largest privately-held agrochemical companies. Dr
Richards joined Arysta LifeScience as Chief Operating Officer in 2003 and was Chief Executive Officer from 2004 to 2010.
Under his leadership, Arysta LifeScience became one of the fastest-growing companies in the agrochemical industry. Arysta
LifeScience was acquired by Permira Funds in 2008.

Dr Richards, aged 58, previously worked in international management roles at Syngenta Crop Protection and at its
predecessor companies Zeneca and ICI. He began his career at the UK Ministry of Agriculture, Fisheries and Food, having
taken a doctorate from St John's College, Oxford.

His other directorships include Dechra Pharmaceuticals plc, the international veterinary pharmaceuticals group listed in
London. He is also non-executive chairman of Oxitec Ltd, the biotech company that is tackling dengue fever and agricultural
pests, and a non-executive director of Cibus Global Inc, the seed technology company.

dlem
04/10/2012
16:58
RNS Number : 1343M
Plant Health Care PLC
13 September 2012

13 September 2012

Plant Health Care plc

("Plant Health Care" or "the Company")

Significant increase in hectares being treated in the SA 2013 maize crop season

Plant Health Care plc, a leading provider of novel patent protected biological products to the global agriculture markets,
is pleased to announce that Insect Science, Ltd ("Insect Science"), its South African distributor for Harpin and Myconate,
has reported significant progress with its Harpin foliar and Myconate seed treatment programmes for the 2013 maize crop
season.

In 2013, its second crop season, Insect Science is increasing the number of maize crop hectares it plans to treat with its
foliar Harpin product by 567% to 100,000 hectares, or 4.5% of the total South African maize crop (2012: 15,000 hectares).
Additionally it plans to increase the number of hectares treated with its Myconate seed treatment by 200% to 60,000
hectares or 2.7% of the total South African maize crop (2012: 20,000 hectares).

John Brady, CEO of Plant Health Care, commented: "Insect Science has made substantial progress into our target market of
foliar applied Harpin as well as seed treated with Myconate. In only its second year of the programme they have achieved
significant market penetration in the very important maize crop in South Africa. We believe, based on very successful
historical maize crop yield increases of approximately 6.5%, that we will continue to experience significant growth in the
coming years."

Charlie Bender, Marketing and Product Development Director of Insect Science, Ltd commented: "We are very pleased with the
rapid growth we are experiencing with the Plant Health Care products. A significant portion of South African potatoes and
pears crops are already treated with these products and we anticipate a similar growth pattern in the maize crop as well.
Farmers have seen strong yield increases with this programme which has significantly enhanced their bottom lines."

- ENDS -

dlem
20/8/2012
17:48
Courtesy of Agrimoney:

US drought hands fillip to Plant Health Care

bobdouthwaite
14/8/2012
06:42
Now we know where Mr Quested might have acquired shares from in July.
parvez
01/8/2012
11:39
Dr Richards said: "I am pleased to be joining Plant Health Care at an inflexion point in the Company's development.



RNS Number : 0562J
Plant Health Care PLC
01 August 2012

1 August 2012

Plant Health Care plc

("Plant Health Care" or "the Company")

Appointment of Chairman

Industry leader Dr Christopher Richards is Plant Health Care's new Chairman

Plant Health Care plc, a leading provider of naturally-derived products to the global agriculture markets, is pleased to
announce the appointment of Dr Christopher Richards as an independent director and non-executive Chairman of the Company,
with immediate effect.

Dr Richards has had a distinguished career in the global agrochemical industry and is the non-executive Chairman of Arysta
LifeScience Corporation ("Arysta LifeScience"), one of the world's largest privately-held agrochemical companies. Dr
Richards joined Arysta LifeScience as Chief Operating Officer in 2003 and was Chief Executive Officer from 2004 to 2010.
Under his leadership, Arysta LifeScience became one of the fastest-growing companies in the agrochemical industry. Arysta
LifeScience was acquired by Permira Funds in 2008.

Dr Richards, aged 58, previously worked in international management roles at Syngenta Crop Protection and at its
predecessor companies Zeneca and ICI. He began his career at the UK Ministry of Agriculture, Fisheries and Food, having
taken a doctorate from St John's College, Oxford.

His other directorships include Dechra Pharmaceuticals plc, the international veterinary pharmaceuticals group listed in
London. He is also non-executive chairman of Oxitec Ltd, the biotech company that is tackling dengue fever and agricultural
pests, and a non-executive director of Cibus Global Inc, the seed technology company.

Following the appointment of Dr Richards, Sam Wauchope steps down as Interim Chairman and returns to his previous role as
Senior Independent Director.

Dr Richards said: "I am pleased to be joining Plant Health Care at an inflexion point in the Company's development. Plant
Health Care has demonstrated that its technology can significantly improve the yields of many important crops, a benefit
that is of considerable commercial potential. I look forward to helping John Brady and his management team realise Plant
Health Care's promise."

John Brady, CEO of Plant Health Care, said: "We are delighted that Chris has joined us. He brings with him a wealth of
experience and I look forward to working with him closely as we enter a very exciting period for the Company."

Save for the information disclosed above there is no other information to be disclosed under Rule 17 or Schedule Two,
paragraph (g) of the AIM Rules for Companies in relation to Dr Christopher Gareth Joseph Richards' appointment as a
director of the Company other than as follows:

Current Directorships Past Directorships
Arysta LifeScience Corporation Arysta LifeScience U.K Limited
Talestris Ltd Arysta LifeScience North America, LLC (formerly Arysta LifeScience North America Corporation, and formerly known as Arvesta Corporation)
Talestris Latinoamerica Inc Arvesta Corporation
Talestris Industrial Inc ANESA S.A
Talestris Colombia SAS Callietha Investments (Pty) Ltd
Fundicom SA Volcano Agroscience (Pty) Ltd
Bio Products Laboratory Ltd Arysta LifeScience Holdings SA (Pty) Ltd (formerly known as Arysta LifeScience South Africa (Pty) Ltd)
Richards Underwriting Limited Arysta LifeScience Global Holding Pte. Ltd. (liquidated 2008)
Dechra plc
Cibus Global Inc.
Oxitec Ltd
Ashridge Court Partnership


- ENDS -

dlem
30/7/2012
13:57
Mr Quested (UAE based businessman) seems like a seasoned investor and has following other holdings:



look slike a man to follows

parvez
27/7/2012
13:19
fantastic announcement and great chart.
parvez
20/7/2012
12:59
74.9% of shares held by 9 Institutional Shareholders, hence the lack of share liquidity and spikes on low volume.

The top 4 Institutional Shareholders control 51.6%

That's not many calls to make to agree a takeover.

The identity and percentage holdings of any significant shareholders - On 17 July 2012, the Company had been notified of the following holdings representing in excess of 3% of the Company's ordinary shares:

Henderson Global Investors Limited 11,098,593 shares 20.83%

ORA (Guernsey) Limited 9,088,853 shares 17.09%

Boulder River Capital Corporation 4,500,000 shares 8.47%

Credit Suisse 2,727,290 5.21%

Aviva plc & its subsidiaries 2,588,938 shares 4.88%

Generation Investment Management LLP 2,355,000 5.26%

Branco Weiss 2,196,954 5.24%

Universities Superannuation Scheme Limited 2,102,500 3.9%

Funds managed by AXA SA for Framlington 1,804,463 4.02%

*The percentages shown are based on the issued share capital as at the date of notification.

dlem
20/7/2012
12:56
2012: Sees an interesting and untypical flurry of activity and interest in PHC

RNS ANNOUNCEMENTS SINCE FEB 2012:

27/02/2012 Encouraging Final results

27/02/2012 Change of Adviser

21/02/2012 ORA (Guernsey) Limited increase from 10%-12% (The principal activity of the company is the growth and development of businesses in which ORA has or acquires a significant shareholding minority or majority shareholding).

23/03/2012 ORA (Guernsey) Limited increase from 12%-13%

05/04/2012 Agreement with MANA Crop Protection

13/04/2012 Chairman resigns suddenly (and Prior to AGM).

17/04/2012 Allotment of shares to directors.

18/04/2012 Henderson Global Investors Crossed below 16%

20/04/2012 AGM Resolutions passed (so Institutional Investors must be content).

20/04/2012 ORA (Guernsey) Limited increase from 13%-14%

25/04/2012 ORA (Guernsey) Limited crossed 16%

27/04/2012 Research Agreement with Arysta LifeScience

01/05/2012 Confirmation of Voting rights

03/05/2012 ORA (Guernsey) Limited crossed 17%

17/05/2012 Research co-operation with University of Arkansas

28/06/2012 Henderson Global Investors Crossed above 16%

17/07/2012 Henderson Global Investors Crossed above 19%

18/07/2012 Henderson Global Investors Crossed above 20%

Substantial and untypical share volumes throughout this period.

dlem
20/7/2012
09:59
Also been a bit of M&A in the sector recently.
vega44
Chat Pages: Latest  18  17  16  15  14  13  12  11  10  9  8  7  Older

Your Recent History

Delayed Upgrade Clock